Novo Nordisk Will Test CagriSema's Long-term Efficacy in Late-stage Trial, Clinicaltrials.gov Entry Shows

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Novo Nordisk will begin a late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10 to test its long-term efficacy, according to a…
Reuters Health Information